top of page
Frequently asked Questions
General
Voxelbox
Neuropsychiatric disorders are the 3rd largest contributor to the global burden of disease. Despite the huge impact they have, and the increasing international focus on them due to the pandemic, the world has not seen revolutionary treatments in this space.
This is because clinicians lack tools that can help in early screening, differential diagnosis and individualized modeling. If they had these tools, they could recruit patients for clinical trials for revolutionary new treatments and therapies, as well as personalize treatment for an individual.
We are here to change that.
Our solution is relevant for the entire healthcare system
- For patients, it helps in much earlier screening and confirmation
- For doctors;
- For psychiatrists: Greater insights into symptoms of patients
- For neurologists and neurosurgeons: Greater precision in diagnosis and prognosis of brain disorders
- For hospitals, it increases the revenue for the hospitals by increasing footfall to the MRI machine, and moving to a scan with higher QALY/dollar
- For pharma companies, it helps in derisking clinical trials
BrainSightAI offers two products:
- Voxelbox, a platform that makes fMRI analysis readily accessible to clinical practitioners for investigating disorders, treatment approaches and surgical planning with an AI powered engine that drastically reduces turnaround time and provides reports with rich insights
-Snowdrop, a companion app for streamlining patient history though a smart combination of symptom tracker, phone sensors and artificial intelligence that acts as a complimentary data source for doctors and therapists
bottom of page